Eric M. Bachelder
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
- Immunology 51
- Immunotherapy and Immune Responses 27
- Immune Cell Function and Interaction 14
- interferon and immune responses 12
- Immune Response and Inflammation 8
-
- RNA Interference and Gene Delivery 26
- Co-authors
- Kristy M. Ainslie (105 shared papers)Tristan T. Beaudette (10 shared papers)Jean M. J. Fréchet (9 shared papers)Kyle E. Broaders (8 shared papers)Matthew D. Gallovic (23 shared papers)Jesse Dashe (3 shared papers)Joel A. Cohen (5 shared papers)Cole J. Batty (26 shared papers)
- Journals
- International Journal of Pharmaceutics (15 papers)Molecular Pharmaceutics (14 papers)Journal of Controlled Release (11 papers)Bioconjugate Chemistry (4 papers)ACS Applied Materials & Interfaces (4 papers)
- Partner nations
- United StatesAustraliaSouth Korea
In The Last Decade
Eric M. Bachelder
112 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 124
- Pharmaceutical Science 563
- Biomaterials 1.1k
- Immunology 1.4k
- Molecular Medicine 164
- Biomedical Engineering 919
Countries citing papers authored by Eric M. Bachelder
This map shows the geographic impact of Eric M. Bachelder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Bachelder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Bachelder more than expected).
Fields of papers citing papers by Eric M. Bachelder
This network shows the impact of papers produced by Eric M. Bachelder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Bachelder. The network helps show where Eric M. Bachelder may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric M. Bachelder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 402 | |
| 2 | 2009 | 262 | |
| 3 | 2018 | 214 | |
| 4 | 2008 | 160 | |
| 5 | 2016 | 131 | |
| 6 | 2017 | 126 | |
| 7 | 2004 | 111 | |
| 8 | 2010 | 109 | |
| 9 | 2010 | 95 | |
| 10 | 2012 | 92 | |
| 11 | 2019 | 79 | |
| 12 | 2018 | 74 | |
| 13 | 2019 | 72 | |
| 14 | 2007 | 71 | |
| 15 | 2018 | 68 | |
| 16 | 2013 | 66 | |
| 17 | 2008 | 66 | |
| 18 | 2018 | 63 | |
| 19 | 2014 | 60 | |
| 20 | 2009 | 60 |
About Eric M. Bachelder
Eric M. Bachelder is a scholar working on Immunology, Molecular Biology, Epidemiology, Biomedical Engineering and Biomaterials, having authored 115 papers that have together received 4.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (27 papers), RNA Interference and Gene Delivery (26 papers), Influenza Virus Research Studies (17 papers), Advanced Drug Delivery Systems (17 papers), Immune Cell Function and Interaction (14 papers), interferon and immune responses (12 papers), Nanoparticle-Based Drug Delivery (12 papers) and Immune Response and Inflammation (8 papers). The work is most often cited by research in Pharmaceutical Science (563 citations), Biomaterials (1.1k citations), Immunology (1.4k citations), Molecular Medicine (164 citations) and Biomedical Engineering (919 citations). Eric M. Bachelder has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Kristy M. Ainslie, Tristan T. Beaudette, Jean M. J. Fréchet, Kyle E. Broaders, Matthew D. Gallovic, Jesse Dashe, Joel A. Cohen, Cole J. Batty, Michael A. Collier and Kevin J. Peine. Their work appears in journals such as International Journal of Pharmaceutics, Molecular Pharmaceutics, Journal of Controlled Release, Bioconjugate Chemistry and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.